Stevanato Group Spa (NYSE: STVN) has a price-to-earnings ratio of 42.20x that is above its average ratio. Additionally, the 36-month beta value for STVN is 0.57. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 2 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for STVN is 49.48M and currently, short sellers hold a 6.90% ratio of that float. The average trading volume of STVN on February 13, 2025 was 375.65K shares.
STVN) stock’s latest price update
Stevanato Group Spa (NYSE: STVN)’s stock price has decreased by -2.91 compared to its previous closing price of 20.09. However, the company has seen a -13.23% decrease in its stock price over the last five trading sessions. zacks.com reported 2025-01-29 that Investors looking for stocks in the Medical – Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now?
STVN’s Market Performance
Stevanato Group Spa (STVN) has experienced a -13.23% fall in stock performance for the past week, with a -9.91% drop in the past month, and a -8.38% drop in the past quarter. The volatility ratio for the week is 5.81%, and the volatility levels for the past 30 days are at 5.38% for STVN. The simple moving average for the past 20 days is -9.74% for STVN’s stock, with a -4.86% simple moving average for the past 200 days.
Analysts’ Opinion of STVN
Many brokerage firms have already submitted their reports for STVN stocks, with Wolfe Research repeating the rating for STVN by listing it as a “Outperform.” The predicted price for STVN in the upcoming period, according to Wolfe Research is $28 based on the research report published on December 13, 2024 of the previous year 2024.
Morgan Stanley, on the other hand, stated in their research note that they expect to see STVN reach a price target of $23. The rating they have provided for STVN stocks is “Equal-Weight” according to the report published on December 03rd, 2024.
STVN Trading at -10.45% from the 50-Day Moving Average
After a stumble in the market that brought STVN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.63% of loss for the given period.
Volatility was left at 5.38%, however, over the last 30 days, the volatility rate increased by 5.81%, as shares sank -11.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.00% lower at present.
During the last 5 trading sessions, STVN fell by -12.68%, which changed the moving average for the period of 200-days by -28.72% in comparison to the 20-day moving average, which settled at $21.62. In addition, Stevanato Group Spa saw -10.49% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for STVN
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.27 for the gross margin
The net margin for Stevanato Group Spa stands at 0.11. The total capital return value is set at 0.09. Equity return is now at value 9.42, with 5.51 for asset returns.
Based on Stevanato Group Spa (STVN), the company’s capital structure generated 0.21 points at debt to capital in total, while cash flow to debt ratio is standing at 0.59. The debt to equity ratio resting at 0.27. The interest coverage ratio of the stock is 28.03.
Currently, EBITDA for the company is 272.35 million with net debt to EBITDA at 1.01. When we switch over and look at the enterprise to sales, we see a ratio of 4.95. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.81.
Conclusion
In conclusion, Stevanato Group Spa (STVN) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
